Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS

Filed by JIM MASSIE & PARTNERS, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 17, 2026
Income
$50,000.00
Expenses
Not reported
Filing UUID
edab13f4-01ac-4aac-9d6f-49083f9d41ba
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

ENG · Energy/Nuclear

Proposed legislation to reauthorize the DOE Isotope Program Appropriations for DOE isotope production Legislation impacting the production and distribution of radiopharmaceuticals S.1241 - Sanctioning Russia Act of 2025 H.R. 2548 - Sanctioning Russia Act of 2025 H.R. 2504 - The U.S. - European Nuclear Energy Cooperation Act H.R. 8106 - To impose sanctions with respect to Rosatom

Literal federal measure citations: S.1241, H.R. 2548, H.R. 2504, H.R. 8106

TRD · Trade (domestic/foreign)

Issues related to the impact of tariffs on the availability of industrial and medical isotopes.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.